DermTech, Inc. logo

DermTech, Inc.

NASDAQ:DMTK

Overview | Financials
Company Name DermTech, Inc.
Symbol DMTK
Currency USD
Price 0.094
Market Cap 3,286,522
Dividend Yield 0%
52-week-range 0.044 - 3.898
Industry Diagnostics & Research
Sector Healthcare
CEO Mr. Bret Christensen
Website https://www.dermtech.com

An error occurred while fetching data.

About DermTech, Inc.

DermTech, Inc., a molecular diagnostic company, develops and markets novel non-invasive genomics tests to diagnosis skin cancer, inflammatory diseases, and aging-related conditions in the United States. It offers DermTech Melanoma Test (DMT), a gene expression test that enhances early detection of genomic atypia and helps rule out melanoma and the

Related Stocks

Immunic, Inc. logo

Immunic, Inc.

IMUX

1.79 USD

Pliant Therapeutics, Inc. logo

Pliant Therapeutics, Inc.

PLRX

12.5 USD

Kronos Bio, Inc. logo

Kronos Bio, Inc.

KRON

0.92 USD

Marinus Pharmaceuticals, Inc. logo

Marinus Pharmaceuticals, Inc.

MRNS

1.51 USD

MoonLake Immunotherapeutics logo

MoonLake Immunotherapeutics

MLTX

53.11 USD

Personalis, Inc. logo

Personalis, Inc.

PSNL

5.52 USD

Sanara MedTech Inc. logo

Sanara MedTech Inc.

SMTI

31.11 USD

Lyra Therapeutics, Inc. logo

Lyra Therapeutics, Inc.

LYRA

0.274 USD

Hyperfine, Inc. logo

Hyperfine, Inc.

HYPR

0.96 USD

Financials

Numbers are in millions USD

Numbers are in millions USD